Evidence map›Paper›PMID 30796555›Full record

ArticleEJNMMI research2019

Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats.

Jakob Albrecht, Dietrich Polenz, Anja A Kühl, Julian M M Rogasch, Annekatrin Leder, Igor M Sauer, Magor Babos, Gabor Mócsai, Nicola Beindorff, Ingo G Steffen and 2 more

Abstract read
In one paragraph

Article in EJNMMI research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Multimodal Imaging of 2-Cycle PRRT withJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jakob AlbrechtDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. jakob.albrecht@charite.de.ORCID http://orcid.org/0000-0003-1684-6302
Dietrich PolenzDepartment of Surgery, Campus Charité Mitte, Luisenstraße 64, 10117, Berlin, Germany.
Anja A KühliPATH.Berlin - Immunopathology for Experimental Models, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Core Unit, Hindenburgdamm 30, 12203, Berlin, Germany.
Julian M M RogaschDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Annekatrin LederDepartment of Surgery, Campus Charité Mitte, Luisenstraße 64, 10117, Berlin, Germany.
Igor M SauerDepartment of Surgery, Campus Charité Mitte, Luisenstraße 64, 10117, Berlin, Germany.
Magor BabosMediso Medical Imaging Systems, Laborc utca 3, Budapest, 1037, Hungary.
Gabor MócsaiMediso Medical Imaging Systems, Laborc utca 3, Budapest, 1037, Hungary.
Nicola BeindorffBerlin Experimental Radionuclide Imaging Center (BERIC), Charité - Universitätsmedizin Berlin, Südstraße 3, 13353, Berlin, Germany.
Ingo G SteffenDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Winfried BrennerDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Eva J KoziolekDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Funding

German Cancer Consortium (DKTK) not applicableZIM Kooperationsprojekt - AiF Projekt GmbH - Projektträger des BMWi (KF2852503AJ3) not applicable
6 · The paper itself

Abstract

backgroundHybrid positron emission tomography and magnetic resonance imaging (PET/MRI) scanners are increasingly used for both clinical and preclinical imaging. Especially functional MRI sequences such as diffusion-weighted imaging (DWI) are of great interest as they provide information on a molecular level, thus, can be used as surrogate biomarkers. Due to technical restrictions, MR sequences need to be adapted for each system to perform reliable imaging. There is, to our knowledge, no suitable DWI protocol for 1 Tesla PET/MRI scanners. We aimed to establish such DWI protocol with focus on the choice of b values, suitable for longitudinal monitoring of tumor characteristics in a rat liver tumor model. MATERIAL AND

methodsDWI was first performed in 18 healthy rat livers using the scanner-dependent maximum of 4 b values (0, 100, 200, 300 s/mm

resultsCompared to the reference measurements, the combination b = 0, 200, 300 s/mm

conclusionWe established a respiratory-gated DWI protocol for a preclinical 1 T PET/MRI scanner allowing to monitor growth-related changes in ADC values of orthotopic HCC liver tumors. By monitoring the changes in tumor ADCs over time, different cellular stages were described. However, each study needs to adapt the protocol further according to their question to generate best possible results.

Indexed as

1 TeslaADCDWIHepatocellular carcinomaPET/MRIPreclinicalRatsTumor microenvironment

Identifiers

PMID30796555
PMCPMC6386759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.